Arcus Biosciences, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RCUS Company Description
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
RCUS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RCUS Smart Score
Score Breakdown
RCUS Company Description
Show More
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RCUS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RCUS's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of RCUS in WallStreetBets Daily Discussion
RCUS News
Recent insights relating to RCUS
CNBC Recommendations
Recent picks made for RCUS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RCUS
Corporate Flights
Flights by private jets registered to RCUS
Our Analysis